NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 72 filers reported holding NOVOCURE LTD in Q1 2017. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $257,746,693 | -61.0% | 15,959,548 | +0.2% | 0.02% | -60.0% |
Q2 2023 | $661,095,961 | -65.2% | 15,930,023 | -49.6% | 0.06% | -36.8% |
Q1 2023 | $1,901,051,504 | +64.7% | 31,610,434 | +100.9% | 0.09% | -24.3% |
Q4 2022 | $1,154,285,368 | -1.6% | 15,736,679 | +1.9% | 0.12% | -5.7% |
Q3 2022 | $1,173,139,000 | +34.6% | 15,440,108 | +23.1% | 0.12% | +40.2% |
Q2 2022 | $871,669,000 | -1.9% | 12,542,006 | +16.9% | 0.09% | +22.5% |
Q1 2022 | $888,969,000 | +51.7% | 10,729,870 | +37.5% | 0.07% | +65.1% |
Q4 2021 | $585,887,000 | -39.1% | 7,803,503 | -5.7% | 0.04% | -43.4% |
Q3 2021 | $961,293,000 | -54.9% | 8,274,887 | -14.0% | 0.08% | -54.5% |
Q2 2021 | $2,133,717,000 | +77.6% | 9,619,135 | +5.8% | 0.17% | +62.1% |
Q1 2021 | $1,201,310,000 | -27.9% | 9,088,439 | -5.6% | 0.10% | -30.4% |
Q4 2020 | $1,665,951,000 | +50.3% | 9,627,554 | -3.3% | 0.15% | +32.1% |
Q3 2020 | $1,108,242,000 | +79.0% | 9,956,360 | -4.6% | 0.11% | +64.7% |
Q2 2020 | $619,005,000 | -22.4% | 10,438,534 | -11.8% | 0.07% | -38.2% |
Q1 2020 | $797,248,000 | -22.3% | 11,839,159 | -2.8% | 0.11% | -2.7% |
Q4 2019 | $1,026,360,000 | +15.3% | 12,179,429 | +2.3% | 0.11% | +5.6% |
Q3 2019 | $890,258,000 | +36.7% | 11,905,031 | +15.5% | 0.11% | +40.8% |
Q2 2019 | $651,477,000 | +29.6% | 10,303,298 | -1.3% | 0.08% | +26.7% |
Q1 2019 | $502,783,000 | +34.2% | 10,437,688 | -6.7% | 0.06% | +17.6% |
Q4 2018 | $374,654,000 | -34.1% | 11,190,381 | +3.2% | 0.05% | -20.3% |
Q3 2018 | $568,292,000 | +130.9% | 10,845,246 | +37.9% | 0.06% | +128.6% |
Q2 2018 | $246,084,000 | +61.7% | 7,862,121 | +12.6% | 0.03% | +55.6% |
Q1 2018 | $152,171,000 | -6.6% | 6,980,345 | -13.5% | 0.02% | -5.3% |
Q4 2017 | $162,937,000 | +5.3% | 8,066,199 | +3.5% | 0.02% | 0.0% |
Q3 2017 | $154,769,000 | +29.9% | 7,796,935 | +13.2% | 0.02% | +26.7% |
Q2 2017 | $119,165,000 | +221.3% | 6,888,120 | +50.4% | 0.02% | +200.0% |
Q1 2017 | $37,086,000 | -3.4% | 4,578,561 | -6.4% | 0.01% | 0.0% |
Q4 2016 | $38,384,000 | -7.9% | 4,889,661 | +0.2% | 0.01% | -16.7% |
Q3 2016 | $41,666,000 | -28.5% | 4,878,970 | -2.3% | 0.01% | -25.0% |
Q2 2016 | $58,304,000 | -27.1% | 4,996,021 | -9.6% | 0.01% | -27.3% |
Q1 2016 | $80,005,000 | -30.9% | 5,525,221 | +6.7% | 0.01% | -31.2% |
Q4 2015 | $115,767,000 | – | 5,177,403 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |